Camille L. Bedrosian - Insider Trading & Ownership

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Camille L. Bedrosian is at least $2M dollars as of October 2, 2024. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981K. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $459K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $117K.
All Insider Reports
All Insider Reports

Ownership of Camille L. Bedrosian

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RARE Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer $981K Mar 1, 2023
AMLX Amylyx Pharmaceuticals, Inc. Chief Medical Officer $459K -$36.6K -7.37% Sep 30, 2024
CRNX Crinetics Pharmaceuticals, Inc. Director $446K Jun 7, 2024
RYTM RHYTHM PHARMACEUTICALS, INC. Director $117K Jun 21, 2024

Insider Transactions Reported by Camille L. Bedrosian:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.